Medication Comparison

Mounjaro vs Compounded Tirzepatide: Which Is Right for You?

A detailed side-by-side comparison of Mounjaro and Compounded Tirzepatide, including cost, side effects, dosing, and provider availability.

At a Glance

Mounjaro

FDA Approved
Eli Lilly
tirzepatide
Type 2 Diabetes (off-label for weight loss)
$0/mo from
15Providers

Compounded Tirzepatide

Compounded
Various compounding pharmacies
tirzepatide
Not FDA-approved as a finished product
$65/mo from
16Providers

Detailed Comparison

FeatureMounjaroCompounded Tirzepatide
Active Ingredienttirzepatidetirzepatide
ManufacturerEli LillyVarious compounding pharmacies
FDA ApprovedYesNo
FDA IndicationType 2 Diabetes (off-label for weight loss)Not FDA-approved as a finished product
Dosing ScheduleOnce weeklyOnce weekly
AdministrationSubcutaneous injection (pen)Subcutaneous injection (vial + syringe)
Starting Price (lowest provider)N/A$65/mo
Provider Count1516
Insurance Coverage10 providers2 providers
Weight Loss DataIn the SURMOUNT-1 trial, patients on the highest dose of tirzepatide (15mg) lost an average of 22.5% of body weight over 72 weeks - the highest weight...As with compounded semaglutide, there are no large clinical trials on compounded tirzepatide specifically. Since it uses the same active ingredient as...

How They Compare

Mounjaro and Compounded Tirzepatide both contain tirzepatide and work through the same mechanism of action. The key difference is that Mounjaro is an FDA-approved brand-name product manufactured by Eli Lilly, while Compounded Tirzepatide is prepared by licensed compounding pharmacies. This typically means Compounded Tirzepatide is significantly more affordable, often costing 60-80% less, but it lacks the specific FDA approval of the brand-name version. Many patients start with the compounded version for cost reasons and may switch to the brand-name product if insurance coverage becomes available.

Side Effects Comparison

Mounjaro

Common

  • Nausea (most common during dose escalation)
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion
  • Abdominal pain

Serious (Rare)

  • Pancreatitis
  • Gallbladder problems
  • Hypoglycemia (especially with insulin)
  • Kidney problems
  • Allergic reactions
  • Thyroid C-cell tumors (boxed warning, animal studies)

Compounded Tirzepatide

Common

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion
  • Abdominal pain

Serious (Rare)

  • Same serious risks as brand-name tirzepatide
  • Pancreatitis
  • Gallbladder problems
  • Kidney injury
  • Thyroid C-cell tumors (theoretical risk)
  • Quality concerns with compounding

Dosing Schedule Comparison

Mounjaro

Subcutaneous injection (pen) - Once weekly

1
2.5 mg
Initiation - Weeks 1-4
2
5 mg
Escalation 1 - Weeks 5-8
3
7.5 mg
Escalation 2 - Weeks 9-12
4
10 mg
Escalation 3 - Weeks 13-16
5
12.5 mg
Escalation 4 - Weeks 17-20
6
15 mg
Maximum - Week 21+

Compounded Tirzepatide

Subcutaneous injection (vial + syringe) - Once weekly

1
2.5 mg
Initiation - Weeks 1-4
2
5 mg
Escalation - Weeks 5-8
3
7.5 mg
Escalation - Weeks 9-12
4
10 mg
Escalation - Weeks 13-16
5
12.5 mg
Escalation - Weeks 17-20
6
15 mg
Maintenance - Week 21+

Frequently Asked Questions

What is the difference between Mounjaro and Compounded Tirzepatide?

Mounjaro (Tirzepatide) is made by Eli Lilly and is FDA-approved. Compounded Tirzepatide (Tirzepatide (compounded)) is made by Various compounding pharmacies and is not FDA-approved as a finished product. Both contain the same active ingredient (tirzepatide) but differ in manufacturing, dosing, and FDA indication.

Which is more affordable, Mounjaro or Compounded Tirzepatide?

Based on available providers, Mounjaro starts at $0/month while Compounded Tirzepatide starts at $65/month. Mounjaro is the more affordable starting option. Actual costs depend on your provider, insurance coverage, and dose level.

Which is more effective for weight loss, Mounjaro or Compounded Tirzepatide?

Both medications have shown significant weight loss results. Clinical trials suggest tirzepatide (dual GIP/GLP-1 agonist) may produce slightly greater average weight loss than semaglutide (GLP-1 agonist alone), though individual results vary significantly. Your healthcare provider can help determine which is best for your specific situation.

Can I switch from Mounjaro to Compounded Tirzepatide?

Switching between GLP-1 medications is possible but should always be done under medical supervision. Your provider will determine the appropriate starting dose for the new medication and may adjust the transition schedule based on your current dose and response. Since both contain the same active ingredient, the transition may be more straightforward.

Find Mounjaro Providers

Compare providers offering Mounjaro near you

Find Providers

Find Compounded Tirzepatide Providers

Compare providers offering Compounded Tirzepatide near you

Find Providers

Related Comparisons

Medical Disclaimer: This comparison is for educational purposes only and should not replace professional medical advice. Individual results vary. Always consult your healthcare provider before starting or changing any medication.